The pandemic has recently been spreading rapidly across the world, posing a formidable challenge to global public health system. As an important measure for the COVID-19 prevention and control, how to improve the capacity of nucleic acid detection has attracted great attention from all countries. As Bior estimates, the cost of one saliva test could reduce from the current €38 to €25, with the use of automatic virus nucleic acid extraction equipment in Latvia. Latvia-based biotech company Lat...

The COVID-19 pandemic is still testing the world in 2021. On January 26th, MGI delivered an automated and integrated nucleic acid testing laboratory (also known as MGI Container Lab) to Medical/Doktor.se, a private clinical group in Sweden. Filip Lind, Business Area Manager at Medical/Doktor.se, said, "In addition to providing packages for COVID testing, the automated & integrated testing laboratory also offers a series of packages to detect other viruses, making it worthy of long-term investme...

As a result of the outbreak of COVID-19, this year's 53rd European Congress of Human Genetics (ESHG 2020) was held online. MGI CSO Dr. Rade Drmanac, Dr. Nik Matthews of Institute of Cancer Research, UK, Prof Miguel Esteban at the Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health, and Prof. Lars Engstrand of Karolinska Institute & Science for Life Laboratory in Sweden shared the latest progress of high-throughput sequencing technologies and valuable experience of utilizin...

In Thailand the rapid and effective development of epidemic prevention and control work has helped to keep the cumulative number of confirmed cases of COVID-19 with just over 3,000. The local disease control system uses a combination of RT-PCR nucleic acid detection technology and high-throughput sequencing technology to confirm the diagnosis of suspected COVID-19 cases and also to launch follow-up research and analysis. As part of this approach, the high-throughput sequencing program adopted by...

13, 2020 – Today, Sinai Health, a significant centre for of key laboratory equipment to increase its COVID-19 detection capability. equipment produced by genomics leader BGI Group, in addition to installation, equipment, is the MGISP-960 automated viral RNA extraction and sample preparation anHealth Canada under the Interim Order. Representatives ceremony in Shenzhen. (Photo: BGI)Nucleic acid testing is essential for clinical donation, Sinai Health hopes to raise its COVID-19 testing throughp...

2. High specificity: No cross-reactivity with 54 human respiratory pathogens 4. Easy interpretation: Analysis of one target with well-defined controls The authorization includes MGI's MGIEasy Nucleic Acid Extraction Kit as a validated method for viral RNA extraction, which is currently in abundant supply worldwide and addresses a severe sample preparation bottleneck for widespread testing. In addition, MGI's robotic sample preparation system significantly improves throughput and reproducibilit...